retatrutide phase 2 trial weight loss 🚨 is out: 24.2% mean and a quarter lost >30%! Women lost more weight than men. #ADA2023 was like drinking from a fire hose for emerging anti-obesity Experimental drug Retatrutide shows promising

A 2021 review of 13 studies reached a similar conclusion, finding that GLP-1 receptor agonist treatment caused between 11.2 to 13.6 pounds of weight loss over periods ranging from 12 to 68 weeks

The Wegovy and Ozempic pens have the needle already built in and hidden inside the base

We encourage individuals to ask questions, verify sources, and seek advice from qualified healthcare professionals before using any weight-loss medication

Low GLP activity is often linked with obesity, insulin resistance, and type 2 diabetes

Nutritionists have been a vital piece of that answer for decades

Steaming vegetables can make them easier to digest while keeping the vitamins intact